M
55
7
LNC
32
3
AAP
32
2
MAT
45
2
FDX
40
4
F
42
2
CMA
48
2
ESS
51
3
XRX
57
-2
BK
65
2
SRE
45
-2
PEP
33
-3
OMC
39
2
MKC
51
-2
D
37
2
HBI
58
2
HCP
54
-2
ROST
66
4
KSS
42
3
TROW
50
2
M
55
7
LNC
32
3
AAP
32
2
MAT
45
2
FDX
40
4
F
42
2
CMA
48
2
ESS
51
3
XRX
57
-2
BK
65
2
SRE
45
-2
PEP
33
-3
OMC
39
2
MKC
51
-2
D
37
2
HBI
58
2
HCP
54
-2
ROST
66
4
KSS
42
3
TROW
50
2
Financhill
Back

Keros Therapeutics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
12

KROS
Keros Therapeutics

Last Price:
$16.55
Seasonality Move:
5.39%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 29.6% based on the past 4 years of stock performance.
  • Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $16.81. The Score for KROS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 29.6% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Sell
12
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
15.67

Prediction Charts

Market Cap:
680.9M
Price in USD:
16.81
Volume:
997.3K
Beta:
1.11

Technical Analysis

SMA50:
52.40
SMA100:
52.46
SMA200:
53.08
52-Wk Change:
-58.23%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 16.81 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 64.50 70.00 70.07 64.46
Dec-9 69.90 67.14 72.37 66.82
Dec-10 67.28 66.31 68.44 65.86
Dec-11 67.76 68.65 69.26 66.48
Dec-12 18.71 18.43 19.34 15.67
Dec-13 18.76 18.83 21.05 17.52
Dec-16 18.25 19.42 19.65 18.08
Dec-17 19.33 18.00 19.40 17.77
Dec-18 18.00 17.13 18.33 16.44
Dec-19 17.08 16.92 17.08 16.31
Dec-20 16.77 17.03 17.64 16.62
Dec-23 16.98 17.12 17.50 16.88
Dec-24 17.12 16.71 17.12 16.63
Dec-26 16.50 16.81 16.89 16.30

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $0.36 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.